AxoGen, Inc. (AXGN)
USD 17.04
(-3.67%)
USD 17.04
(-3.67%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -21.71 Million USD | 20.56% |
| 2022 | -27.33 Million USD | 2.59% |
| 2021 | -28.06 Million USD | -13.15% |
| 2020 | -24.8 Million USD | 14.83% |
| 2019 | -29.12 Million USD | -30.03% |
| 2018 | -22.39 Million USD | -114.42% |
| 2017 | -10.44 Million USD | 27.52% |
| 2016 | -14.41 Million USD | -7.9% |
| 2015 | -13.35 Million USD | 24.58% |
| 2014 | -17.71 Million USD | -21.66% |
| 2013 | -14.55 Million USD | -54.57% |
| 2012 | -9.41 Million USD | -2.16% |
| 2011 | -9.21 Million USD | -600.39% |
| 2010 | -1.31 Million USD | -108.75% |
| 2009 | 15.04 Million USD | 1545.78% |
| 2008 | -1.04 Million USD | -38.95% |
| 2007 | -748.98 Thousand USD | -103.98% |
| 2006 | -367.18 Thousand USD | 30.8% |
| 2005 | -530.61 Thousand USD | -123.1% |
| 2004 | 2.29 Million USD | 279.18% |
| 2003 | -1.28 Million USD | 50.75% |
| 2002 | -2.6 Million USD | -293.73% |
| 2001 | 1.34 Million USD | 146.99% |
| 2000 | -2.85 Million USD | -68.19% |
| 1999 | -1.7 Million USD | -325.0% |
| 1998 | -400 Thousand USD | 82.61% |
| 1997 | -2.3 Million USD | -283.33% |
| 1996 | -600 Thousand USD | -400.0% |
| 1995 | 200 Thousand USD | -66.67% |
| 1994 | 600 Thousand USD | -14.29% |
| 1993 | 700 Thousand USD | -30.0% |
| 1992 | 1 Million USD | 11.11% |
| 1991 | 900 Thousand USD | 125.0% |
| 1990 | 400 Thousand USD | -33.33% |
| 1989 | 600 Thousand USD | -33.33% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.92 Million USD | 71.05% |
| 2024 Q1 | -6.63 Million USD | -70.43% |
| 2023 Q1 | -6.71 Million USD | -30.82% |
| 2023 Q2 | -6.66 Million USD | 0.75% |
| 2023 Q3 | -4.08 Million USD | 38.6% |
| 2023 FY | -21.71 Million USD | 20.56% |
| 2023 Q4 | -3.89 Million USD | 4.79% |
| 2022 Q3 | -3.66 Million USD | 52.67% |
| 2022 Q4 | -5.12 Million USD | -40.02% |
| 2022 FY | -27.33 Million USD | 2.59% |
| 2022 Q1 | -11.26 Million USD | -113.19% |
| 2022 Q2 | -7.74 Million USD | 31.32% |
| 2021 Q4 | -5.28 Million USD | 25.98% |
| 2021 Q2 | -7.89 Million USD | -18.59% |
| 2021 Q1 | -6.66 Million USD | -10.82% |
| 2021 Q3 | -7.14 Million USD | 9.58% |
| 2021 FY | -28.06 Million USD | -13.15% |
| 2020 Q1 | -8.19 Million USD | -16.4% |
| 2020 FY | -24.8 Million USD | 14.83% |
| 2020 Q2 | -8.1 Million USD | 1.06% |
| 2020 Q3 | -1.47 Million USD | 81.75% |
| 2020 Q4 | -6.01 Million USD | -306.36% |
| 2019 Q3 | -5.57 Million USD | 20.67% |
| 2019 Q1 | -9.5 Million USD | -81.93% |
| 2019 Q2 | -7.02 Million USD | 26.1% |
| 2019 FY | -29.12 Million USD | -30.03% |
| 2019 Q4 | -7.03 Million USD | -26.33% |
| 2018 Q2 | -7.42 Million USD | -31.73% |
| 2018 Q1 | -5.63 Million USD | -125.62% |
| 2018 Q3 | -4.1 Million USD | 44.78% |
| 2018 FY | -22.39 Million USD | -114.42% |
| 2018 Q4 | -5.22 Million USD | -27.36% |
| 2017 Q4 | -2.49 Million USD | -17.66% |
| 2017 FY | -10.44 Million USD | 27.52% |
| 2017 Q2 | -2.06 Million USD | 45.24% |
| 2017 Q3 | -2.12 Million USD | -3.1% |
| 2017 Q1 | -3.76 Million USD | 33.14% |
| 2016 FY | -14.41 Million USD | -7.9% |
| 2016 Q4 | -5.62 Million USD | -144.08% |
| 2016 Q2 | -2.8 Million USD | 23.76% |
| 2016 Q3 | -2.3 Million USD | 17.74% |
| 2016 Q1 | -3.67 Million USD | -1.79% |
| 2015 Q3 | -2.97 Million USD | 6.64% |
| 2015 Q1 | -3.57 Million USD | 44.92% |
| 2015 FY | -13.35 Million USD | 24.58% |
| 2015 Q4 | -3.61 Million USD | -21.24% |
| 2015 Q2 | -3.19 Million USD | 10.75% |
| 2014 Q2 | -3.74 Million USD | 11.75% |
| 2014 FY | -17.71 Million USD | -21.66% |
| 2014 Q1 | -4.23 Million USD | -3.18% |
| 2014 Q3 | -3.23 Million USD | 13.45% |
| 2014 Q4 | -6.49 Million USD | -100.46% |
| 2013 FY | -14.55 Million USD | -54.57% |
| 2013 Q4 | -4.1 Million USD | -15.65% |
| 2013 Q3 | -3.55 Million USD | -2.75% |
| 2013 Q2 | -3.45 Million USD | -0.59% |
| 2013 Q1 | -3.43 Million USD | 14.96% |
| 2012 Q4 | -4.04 Million USD | -80.71% |
| 2012 Q3 | -2.23 Million USD | -117.23% |
| 2012 Q2 | -1.02 Million USD | 51.18% |
| 2012 Q1 | -2.1 Million USD | 1.29% |
| 2012 FY | -9.41 Million USD | -2.16% |
| 2011 Q4 | -2.13 Million USD | 31.36% |
| 2011 FY | -9.21 Million USD | -600.39% |
| 2011 Q1 | 905.21 Thousand USD | 341.34% |
| 2011 Q2 | 250.43 Thousand USD | -72.33% |
| 2011 Q3 | -3.11 Million USD | -1343.09% |
| 2010 FY | -1.31 Million USD | -108.75% |
| 2010 Q4 | -375.07 Thousand USD | 19.32% |
| 2010 Q1 | -245.92 Thousand USD | -101.62% |
| 2010 Q2 | -230.38 Thousand USD | 6.32% |
| 2010 Q3 | -464.91 Thousand USD | -101.79% |
| 2009 FY | 15.04 Million USD | 1545.78% |
| 2009 Q1 | -134.46 Thousand USD | -11.32% |
| 2009 Q2 | 138.99 Thousand USD | 203.37% |
| 2009 Q3 | -130.97 Thousand USD | -194.23% |
| 2009 Q4 | 15.17 Million USD | 11684.57% |
| 2008 Q4 | -120.79 Thousand USD | 79.28% |
| 2008 Q2 | -177.37 Thousand USD | -11.07% |
| 2008 Q1 | -159.7 Thousand USD | -716.14% |
| 2008 FY | -1.04 Million USD | -38.95% |
| 2008 Q3 | -582.83 Thousand USD | -228.59% |
| 2007 Q4 | -19.56 Thousand USD | 95.72% |
| 2007 Q3 | -456.99 Thousand USD | -189.07% |
| 2007 Q2 | -158.09 Thousand USD | -38.28% |
| 2007 Q1 | -114.32 Thousand USD | 22.55% |
| 2007 FY | -748.98 Thousand USD | -103.98% |
| 2006 FY | -367.18 Thousand USD | 30.8% |
| 2006 Q4 | -147.62 Thousand USD | -138.39% |
| 2006 Q3 | -61.92 Thousand USD | 41.61% |
| 2006 Q2 | -106.06 Thousand USD | -105.65% |
| 2006 Q1 | -51.57 Thousand USD | -136.95% |
| 2005 Q3 | 379.00 USD | 100.46% |
| 2005 FY | -530.61 Thousand USD | -123.1% |
| 2005 Q4 | 139.57 Thousand USD | 36727.18% |
| 2005 Q2 | -82.31 Thousand USD | 86.01% |
| 2005 Q1 | -588.24 Thousand USD | -156.47% |
| 2004 Q1 | 74.72 Thousand USD | 151.56% |
| 2004 Q3 | 1.17 Million USD | 13152.87% |
| 2004 Q4 | 1.04 Million USD | -11.07% |
| 2004 Q2 | 8839.00 USD | -88.17% |
| 2004 FY | 2.29 Million USD | 279.18% |
| 2003 Q3 | -343.79 Thousand USD | 20.7% |
| 2003 Q4 | -144.93 Thousand USD | 57.84% |
| 2003 Q1 | -359.48 Thousand USD | 45.34% |
| 2003 FY | -1.28 Million USD | 50.75% |
| 2003 Q2 | -433.54 Thousand USD | -20.6% |
| 2002 Q2 | -768 Thousand USD | 4.83% |
| 2002 FY | -2.6 Million USD | -293.73% |
| 2002 Q3 | -370.46 Thousand USD | 51.76% |
| 2002 Q4 | -657.73 Thousand USD | -77.55% |
| 2002 Q1 | -806.98 Thousand USD | 0.0% |
| 2001 Q3 | -1.19 Million USD | -137.45% |
| 2001 FY | 1.34 Million USD | 146.99% |
| 2001 Q1 | -543.78 Thousand USD | 21.42% |
| 2001 Q2 | 3.17 Million USD | 684.27% |
| 2000 FY | -2.85 Million USD | -68.19% |
| 2000 Q2 | -817.49 Thousand USD | -27.07% |
| 2000 Q1 | -643.32 Thousand USD | 19.58% |
| 2000 Q4 | -691.99 Thousand USD | -15.74% |
| 2000 Q3 | -597.9 Thousand USD | 26.86% |
| 1999 Q1 | -300 Thousand USD | 57.14% |
| 1999 Q2 | -500 Thousand USD | -66.67% |
| 1999 Q3 | -600 Thousand USD | -20.0% |
| 1999 Q4 | -800 Thousand USD | -33.33% |
| 1999 FY | -1.7 Million USD | -325.0% |
| 1998 FY | -400 Thousand USD | 82.61% |
| 1998 Q3 | -200 Thousand USD | 33.33% |
| 1998 Q4 | -700 Thousand USD | -250.0% |
| 1998 Q2 | -300 Thousand USD | 0.0% |
| 1998 Q1 | -300 Thousand USD | 0.0% |
| 1997 Q1 | -1.5 Million USD | -400.0% |
| 1997 FY | -2.3 Million USD | -283.33% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q3 | 200 Thousand USD | 133.33% |
| 1997 Q2 | -600 Thousand USD | 60.0% |
| 1996 FY | -600 Thousand USD | -400.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | -300 Thousand USD | 0.0% |
| 1996 Q2 | - USD | -100.0% |
| 1996 Q1 | 100 Thousand USD | 114.29% |
| 1995 Q3 | -100 Thousand USD | 0.0% |
| 1995 Q1 | 200 Thousand USD | 0.0% |
| 1995 FY | 200 Thousand USD | -66.67% |
| 1995 Q4 | -700 Thousand USD | -600.0% |
| 1995 Q2 | -100 Thousand USD | -150.0% |
| 1994 Q1 | - USD | -100.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 FY | 600 Thousand USD | -14.29% |
| 1994 Q4 | - USD | -100.0% |
| 1994 Q2 | - USD | 0.0% |
| 1993 FY | 700 Thousand USD | -30.0% |
| 1993 Q3 | 400 Thousand USD | 100.0% |
| 1993 Q4 | 200 Thousand USD | -50.0% |
| 1993 Q1 | 200 Thousand USD | 100.0% |
| 1993 Q2 | 200 Thousand USD | 0.0% |
| 1992 Q2 | 200 Thousand USD | 0.0% |
| 1992 Q4 | 100 Thousand USD | -50.0% |
| 1992 Q3 | 200 Thousand USD | 0.0% |
| 1992 Q1 | 200 Thousand USD | -33.33% |
| 1992 FY | 1 Million USD | 11.11% |
| 1991 Q1 | 200 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | 0.0% |
| 1991 FY | 900 Thousand USD | 125.0% |
| 1991 Q3 | 300 Thousand USD | 50.0% |
| 1991 Q2 | 200 Thousand USD | 0.0% |
| 1990 FY | 400 Thousand USD | -33.33% |
| 1990 Q2 | -2.1 Million USD | -950.0% |
| 1990 Q1 | -200 Thousand USD | 0.0% |
| 1990 Q4 | 200 Thousand USD | 0.0% |
| 1990 Q3 | 200 Thousand USD | 109.52% |
| 1989 Q1 | - USD | 0.0% |
| 1989 FY | 600 Thousand USD | -33.33% |
| 1989 Q4 | - USD | -100.0% |
| 1989 Q3 | 200 Thousand USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 73.408% |
| Cerus Corporation | -37.48 Million USD | 42.074% |
| OrthoPediatrics Corp. | -20.97 Million USD | -3.538% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -98.224% |
| Talis Biomedical Corporation | -62 Million USD | 64.978% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -59.876% |
| Inogen, Inc. | -102.44 Million USD | 78.803% |
| Spectral AI, Inc. | -20.85 Million USD | -4.133% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 64.269% |
| CVRx, Inc. | -41.19 Million USD | 47.29% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 3492.086% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -145.379% |
| Orthofix Medical Inc. | -151.39 Million USD | 85.656% |
| Venus Concept Inc. | -37.25 Million USD | 41.702% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 64.757% |
| Bioventus Inc. | -156.23 Million USD | 86.1% |
| BrainsWay Ltd. | -4.19 Million USD | -417.417% |
| Envoy Medical, Inc. | -29.9 Million USD | 27.391% |
| electroCore, Inc. | -18.83 Million USD | -15.302% |
| IceCure Medical Ltd | -14.65 Million USD | -48.212% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 58.767% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -57.99% |
| MaxCyte, Inc. | -37.92 Million USD | 42.737% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -83.111% |
| Nexalin Technology, Inc. | -4.64 Million USD | -367.14% |
| PAVmed Inc | -64.17 Million USD | 66.161% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 58.61% |
| RxSight, Inc. | -48.6 Million USD | 55.324% |
| Sight Sciences, Inc. | -55.54 Million USD | 60.905% |
| SI-BONE, Inc. | -43.33 Million USD | 49.889% |
| TELA Bio, Inc. | -46.66 Million USD | 53.463% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 63.217% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 56.153% |
| LivaNova PLC | 17.54 Million USD | 223.766% |
| 908 Devices Inc. | -36.39 Million USD | 40.339% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 88.365% |
| Nemaura Medical Inc. | -14.14 Million USD | -53.538% |
| NeuroPace, Inc. | -32.95 Million USD | 34.106% |
| LENSAR, Inc. | -14.38 Million USD | -50.984% |
| Apyx Medical Corporation | -18.71 Million USD | -16.048% |
| Cutera, Inc. | -162.83 Million USD | 86.664% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -100.517% |
| BioSig Technologies, Inc. | -29.04 Million USD | 25.223% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 73.731% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 1.689% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 132.057% |
| Axonics, Inc. | -6.08 Million USD | -256.702% |
| Outset Medical, Inc. | -172.79 Million USD | 87.433% |
| IRIDEX Corporation | -9.57 Million USD | -126.917% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 79.493% |
| IRadimed Corporation | 17.19 Million USD | 226.309% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -163.416% |
| INVO Bioscience, Inc. | -8.03 Million USD | -170.281% |
| Telesis Bio, Inc. | -47.72 Million USD | 54.497% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 312.008% |
| Varex Imaging Corporation | -47.7 Million USD | 54.474% |
| Quipt Home Medical Corp. | -2.78 Million USD | -680.029% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -92.415% |
| Pulmonx Corporation | -60.84 Million USD | 64.308% |
| Dynatronics Corporation | -2.69 Million USD | -704.976% |
| Modular Medical, Inc. | -17.47 Million USD | -24.305% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -90.709% |
| Semler Scientific, Inc. | 20.58 Million USD | 205.505% |
| InMode Ltd. | 197.91 Million USD | 110.972% |
| Bruker Corporation | 427.2 Million USD | 105.083% |
| Cytosorbents Corporation | -28.5 Million USD | 23.823% |
| DexCom, Inc. | 541.5 Million USD | 104.01% |
| Align Technology, Inc. | 445.05 Million USD | 104.879% |
| Viveve Medical, Inc. | -22.02 Million USD | 1.412% |
| ZimVie Inc. | -393.28 Million USD | 94.478% |
| Movano Inc. | -29.28 Million USD | 25.841% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -78.762% |
| Nexalin Technology, Inc. | -4.64 Million USD | -367.14% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 3492.086% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 90.245% |
| Profound Medical Corp. | -28.56 Million USD | 23.988% |
| Insulet Corporation | 206.3 Million USD | 110.526% |
| enVVeno Medical Corporation | -23.51 Million USD | 7.654% |
| Surmodics, Inc. | -11.54 Million USD | -88.148% |
| iCAD, Inc. | -4.84 Million USD | -348.03% |
| Nuwellis, Inc. | -20.2 Million USD | -7.457% |
| Biotricity, Inc. | -14.09 Million USD | -54.077% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 82.403% |
| Aethlon Medical, Inc. | -12.2 Million USD | -77.881% |
| InspireMD, Inc. | -19.91 Million USD | -9.038% |
| PAVmed Inc. | -64.17 Million USD | 66.161% |
| BIOLASE, Inc. | -20.63 Million USD | -5.254% |
| Beyond Air, Inc. | -60.24 Million USD | 63.952% |
| FONAR Corporation | 10.56 Million USD | 305.5% |
| Vivani Medical, Inc. | -25.65 Million USD | 15.344% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 176.156% |
| Inari Medical, Inc. | -1.63 Million USD | -1227.384% |
| UFP Technologies, Inc. | 44.92 Million USD | 148.339% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -323.121% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -228.771% |
| Tenon Medical, Inc. | -15.58 Million USD | -39.375% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -40.775% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 38.539% |
| AdaptHealth Corp. | -678.89 Million USD | 96.801% |
| Sintx Technologies, Inc. | -8.25 Million USD | -162.937% |
| NanoVibronix, Inc. | -3.71 Million USD | -485.179% |
| Quanterix Corporation | -32.33 Million USD | 32.838% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -92.415% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 4577.526% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 92.92% |
| TransMedics Group, Inc. | -25.02 Million USD | 13.233% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 1.884% |
| NeuroMetrix, Inc. | -6.52 Million USD | -232.584% |
| Hyperfine, Inc. | -44.23 Million USD | 50.911% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 72.337% |
| Biomerica, Inc. | -5.97 Million USD | -263.265% |
| Bone Biologics Corporation | -8.94 Million USD | -142.671% |
| AVITA Medical, Inc. | -39.16 Million USD | 44.557% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -118.166% |
| Silk Road Medical, Inc | -55.74 Million USD | 61.043% |